Raninga PV, Zeng B, Moi D, Trethowan E, et al. CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers. Oncogene 2025;44:893-908.
PMID: 39706891